Nalaganje...

Pharmacogenomic Assessment of Patients with Colorectal Cancer and Potential Treatments

Evolving intensiveness of colorectal cancer (CRC) treatment, including chemotherapeutics and targeted agents associations, in adjuvant and metastatic CRC (MCRC) settings, increased overall survival (OS) with individual variability of toxicity. Pharmacogenomic guidelines recommended pre-treatment ide...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Pharmgenomics Pers Med
Main Authors: Bruera, Gemma, Ricevuto, Enrico
Format: Artigo
Jezik:Inglês
Izdano: Dove 2020
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7678498/
https://ncbi.nlm.nih.gov/pubmed/33235483
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PGPM.S253586
Oznake: Označite
Brez oznak, prvi označite!